alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING

MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL

OF FLORIDA

SECOND DISTRICT

TIMOTHY BEY, a/k/a TIMOTHY DORTCH, )

JR., )

)

Appellant, )

)

v. ) Case No. 2D18-275

)

STATE OF FLORIDA, )

)

Appellee. )

___________________________________)

Opinion filed July 6, 2018.

Appeal pursuant to Fla. R. App. P.

9.141(b)(2) from the Circuit Court 

for Lee County; Bruce Kyle, Judge.

Timothy Bey, pro se.

PER CURIAM.

Affirmed. See Carbajal v. State, 75 So. 3d 258 (Fla. 2011); Johnson v. 

State, 974 So. 2d 363 (Fla. 2008); Logan v. State, 846 So. 2d 472 (Fla. 2003); State v. 

King, 426 So. 2d 12 (Fla. 1982); Harris v. State, 818 So. 2d 567 (Fla. 2d DCA 2002).

CASANUEVA, LUCAS, and BADALAMENTI, JJ., Concur.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [Release No. 34-56809; File No. SR-Amex-2007-116]

      ( print page 70374)    

### Correction

In notice document E7-22974 beginning on page 66203 in the issue of Tuesday, November 27, 2007, make the following correction:

On page 66205, in the second column, in the third paragraph, in the last line, “December 17, 2007” should read “December 18, 2007”.

[FR Doc. Z7-22974 Filed 12-10-07; 8:45 am]

BILLING CODE 1505-01-D
# C_2020370EN.01004001.xml

| 3.11.2020 | EN | Official Journal of the European Union | C 370/40 |
| --- | --- | --- | --- |

3.11.2020

EN

Official Journal of the European Union

C 370/40

---

FUSION FOR ENERGY JOINT UNDERTAKING

Publication of the final accounts for the financial year 2019

(2020/C 370/40)

The complete version of the final accounts may be found at the following address:

https://fusionforenergy.europa.eu/key-reference-documents/

---
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL OF FLORIDA SECOND DISTRICT

STATE OF FLORIDA, ) ) Appellant, ) ) v. ) Case No. 2D17-2078 ) DWIGHT DUBOSE, DOC #116869, ) ) Appellee. ) ) Opinion filed February 14, 2018. Appeal from the Circuit Court for Hillsborough County; Lisa D. Campbell, Judge. Pamela Jo Bondi, Attorney General, Tallahassee, and Donna S. Koch, Assistant Attorney General, Tampa, for Appellant. Melissa Montle, and Seth E. Miller, of Innocence Project of Florida, Inc., Tallahassee, for Appellee.

PER CURIAM.

Affirmed.

MORRIS, BLACK, and BADALAMENTI, JJ., Concur.
<PAGE>

                                  Exhibit 99.1

    Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

<PAGE>

                                                                    Exhibit 99.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                                   AS ADDED BY
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report of Florida Savings Bancorp, Inc.
(the "Company") on Form 10-KSB for the year ended December 31, 2002 as filed
with the Securities and Exchange Commission (the "Report"), I, Bernard Janis,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. (S)1350,
as added by 906 of the Sarbanes-Oxley Act of 2002, that:

          (1)  The Report fully complies with the requirements of Section 13(a)
               or 15(d) of the Securities Exchange Act of 1934; and

          (2)  To my knowledge, the information contained in the Report fairly
               presents, in all material respects, the financial condition and
               results of operations of the Company as of and for the period
               covered by the Report.

                                         /s/ Bernard Janis
                                        ------------------------------
                                        Bernard Janis
                                        Chief Executive Officer

March 31, 2003

<PAGE>

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                                   AS ADDED BY
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report of Florida Savings Bancorp, Inc.
(the "Company") on Form 10-KSB for the year ended December 31, 2002 as filed
with the Securities and Exchange Commission (the "Report"), I, David P. Stark,
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. (S)1350,
as added by 906 of the Sarbanes-Oxley Act of 2002, that:

          (1)  The Report fully complies with the requirements of Section 13(a)
               or 15(d) of the Securities Exchange Act of 1934; and

          (2)  To my knowledge, the information contained in the Report fairly
               presents, in all material respects, the financial condition and
               results of operations of the Company as of and for the period
               covered by the Report.

                                        /s/ David P. Stark
                                        ------------------------------
                                        David P. Stark

March 31, 2003
FIRST DISTRICT COURT OF APPEAL

STATE OF FLORIDA

_____________________________

No. 1D17-145

_____________________________

VONCHAE JAROD SIMPKINS,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

___________________________

On appeal from the Circuit Court for Escambia County.

Jennie M. Kinsey, Judge.

January 22, 2018

PER CURIAM.

AFFIRMED. 

B.L. THOMAS, C.J., and WETHERELL and WINSOR, JJ., concur.

_____________________________

Not final until disposition of any timely and 

authorized motion under Fla. R. App. P. 9.330 or 

9.331.

_____________________________

Andy Thomas, Public Defender, Joel Arnold, Assistant Public 

Defender, Tallahassee, for Appellant.

Pamela Jo Bondi, Attorney General, Tallahassee, for Appellee.
STATE of Louisiana v. James R. TOWNLEY, Jr.

NO. 2018-KH-1181

Supreme Court of Louisiana.

October 29, 2018

Denied.
# C_2020072EN.01001301.xml

| 5.3.2020 | EN | Official Journal of the European Union | C 72/13 |
| --- | --- | --- | --- |

5.3.2020

EN

Official Journal of the European Union

C 72/13

---

Prior notification of a concentration

(Case M.9517 — Mylan/Upjohn)

(Text with EEA relevance)

(2020/C 72/10)

1.

This notification concerns the following undertakings:

| — | Mylan N.V. (‘Mylan’, the Netherlands), |
| --- | --- |

—

Mylan N.V. (‘Mylan’, the Netherlands),

| — | Upjohn Inc. (‘Upjohn’, China), controlled by Pfizer Inc. (‘Pfizer’, USA). |
| --- | --- |

—

Upjohn Inc. (‘Upjohn’, China), controlled by Pfizer Inc. (‘Pfizer’, USA).

Mylan and Upjohn enter into a full merger within the meaning of Article 3(1)(a) of the Merger Regulation by way of several transaction steps, including the transfer of shares and assets.

2.

| — | for Mylan: Mylan develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals in addition to over-the-counter and consumer healthcare products. |
| --- | --- |

—

for Mylan: Mylan develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals in addition to over-the-counter and consumer healthcare products.

| — | for Upjohn: Upjohn is a business division of Pfizer which operates a portfolio of off-patent branded and generic medicines, as well as a generic business in the United-States under Greenstone LLC. |
| --- | --- |

—

for Upjohn: Upjohn is a business division of Pfizer which operates a portfolio of off-patent branded and generic medicines, as well as a generic business in the United-States under Greenstone LLC.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9517 – Mylan/Upjohn

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       5,064,108
<SECURITIES>                                         0
<RECEIVABLES>                                1,357,142
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             7,108,689
<PP&E>                                       4,077,388
<DEPRECIATION>                                 449,698
<TOTAL-ASSETS>                              10,770,041
<CURRENT-LIABILITIES>                        2,058,315
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                 13,068,160
<COMMON>                                     5,109,786
<OTHER-SE>                                (10,671,586)
<TOTAL-LIABILITY-AND-EQUITY>                10,770,041
<SALES>                                      5,254,078
<TOTAL-REVENUES>                             5,254,078
<CGS>                                        3,385,674
<TOTAL-COSTS>                               10,555,434
<OTHER-EXPENSES>                           (1,038,541)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (61,144)
<INCOME-PRETAX>                            (9,786,715)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (9,786,715)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (9,786,715)
<EPS-BASIC>                                     (0.14)
<EPS-DILUTED>                                   (0.14)


</TABLE>
# C_2020131EN.01002201.xml

| 22.4.2020 | EN | Official Journal of the European Union | C 131/22 |
| --- | --- | --- | --- |

22.4.2020

EN

Official Journal of the European Union

C 131/22

---

Prior notification of a concentration

(Case M.9772 – Helvetia/CASER)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 131/10)

1.

This notification concerns the following undertakings:

| — | Helvetia Schweizerische Versicherungsgesellschaft AG (‘Helvetia’, Switzerland), ultimately controlled by Helvetia Holding AG, |
| --- | --- |

—

Helvetia Schweizerische Versicherungsgesellschaft AG (‘Helvetia’, Switzerland), ultimately controlled by Helvetia Holding AG,

| — | Caja de Seguros Reunidos, Compañía de Seguros y Reaseguros, S.A (‘CASER’, Spain). |
| --- | --- |

—

Caja de Seguros Reunidos, Compañía de Seguros y Reaseguros, S.A (‘CASER’, Spain).

Helvetia acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of CASER.

The concentration is accomplished by way of purchase of shares.

2.

| — | CASER: Spanish group focused on the insurance business, as well as the provision of healthcare services, dental clinics, or care home services. |
| --- | --- |

—

CASER: Spanish group focused on the insurance business, as well as the provision of healthcare services, dental clinics, or care home services.

| — | Helvetia: Swiss all-lines insurer, also present in certain European Union Member States (such as Germany, Austria, France, Italy, and Spain). It is ultimately controlled by Helvetia Holding AG, a Swiss company listed in the Swiss stock exchange. |
| --- | --- |

—

Helvetia: Swiss all-lines insurer, also present in certain European Union Member States (such as Germany, Austria, France, Italy, and Spain). It is ultimately controlled by Helvetia Holding AG, a Swiss company listed in the Swiss stock exchange.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9772 – Helvetia/CASER

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---
EXHIBIT 32





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT of 2002











Pursuant to Section 906 of the Sarbanes-Oxley Act 2002 (18 U.S.C. 1350), the undersigned, Henry Ligouri, Chief Executive Officer, and Henry Ligouri, acting Chief Financial Officer of Wavelit, Inc. (formerly Infotec Business Systems, Inc.) (“the Company”) have executed this certification
in connection with the filing with the Securities and Exchange Commission of the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2009 (“the Report”).





The undersigned certifies that: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of
the Company.





IN WITNESS WHEREOF, the undersigned has executed this certification as of the 12th day of August 2009.











/s/ Henry Liguori


Henry Liguori, Chief Executive Officer








/s/ Henry Liguori


Henry Liguori, Chief Financial Officer
**Exhibit 31.1**

 

**CERTIFICATION**

 

I, William Fox,certify that:

 

1.               I have reviewed this annual report on Form 10-K,and all reports on Form 8-K containing distribution or servicing reportsfiled in respect of periods included in the year covered by this annual report,of Lehman ABS Corporation, on behalf of Corporate Backed Trust Certificates,Ford Motor Company Note-Backed Series 2003-6 Trust****(the“Trust”);

 

2.               Based on my knowledge, the information in thesereports, taken as a whole, does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading as of the last day of the period covered by this annual report;

 

3.               Based on my knowledge, the distribution or servicinginformation required to be provided to the Depositor by the Trustee under thepooling and servicing, or similar, agreement, for inclusion in these reports isincluded in these reports; and

 

4.               I am responsible for reviewing the activitiesperformed by the Depositor and the Trustee under the pooling and servicing, orsimilar, agreement and based upon my knowledge and the annual compliance reviewrequired under that agreement, and except as disclosed in the reports, theDepositor and Trustee have each fulfilled its obligations under that agreement.

 

In giving thecertifications above, I have reasonably relied on information provided to me bythe following unaffiliated party: U.S. Bank Trust National Association, asTrustee.

 

Date: July 20, 2009

 

 
| **By:**    | **/s/ William Fox**                          |       |
|------------|----------------------------------------------|------------|
| **Name:**  | **William Fox**                              | ** ** |
| **Title:** | **Chief Financial Officer,  Controller and** | ** ** |
|       | **Senior Vice President**                    | ** ** |

 

----
# C_2020246EN.01000201.xml

| 27.7.2020 | EN | Official Journal of the European Union | C 246/2 |
| --- | --- | --- | --- |

27.7.2020

EN

Official Journal of the European Union

C 246/2

---

Special Report No 17/2020

‘Trade defence instruments: system for protecting EU businesses from dumped and subsidised imports functions well’

(2020/C 246/02)

The European Court of Auditors hereby informs you that Special Report No 17/2020

‘Trade defence instruments: system for protecting EU businesses from dumped and subsidised imports functions well’ has just been published. The report can be accessed for consultation or downloading on the European Court of Auditors’ website: http://eca.europa.eu

---
IN THE SUPREME COURT OF THE STATE OF DELAWARE

PATRICIA O’ROURKE

, §

§ No. 91, 2022

Plaintiff Below, §

Appellant s

, § Court Below

— Superior Court

§ of the State of Delaware

v. §

§ C .A. No: N20C

- 08

- 064

PNC BANK

, §

§

Defendant s Below, §

Appellee s

. §

Submitted: November 2 , 2022

Decided: November 21 , 2022

Before SEITZ

, Chief Justice; VAUG H N and TRAYNOR

, Justices

.

ORDER

This 21 st day of November , 2022

, after consideration of the parties’ briefs and

the record on appeal, it appears to the Court that the judgment of the Superior Court

should be affirmed on the basis of and for the reasons stated in its February 15, 2022

Memorandum Opinion.

NOW, THEREFORE, IT IS ORDERED that the judgment of the Superior

Court is AFFIRMED.

BY THE COURT:

/s/ Gary F. Traynor

Justice
Wilbert JONES v. Timothy HOOPER, Warden

NO. 2017-KP-2012

Supreme Court of Louisiana.

October 8, 2018

Denied.

WEIMER, J., would grant.
Ronnie CLAUSELL, Appellant, v. STATE of Florida, Appellee.

No. 1D18-2285

District Court of Appeal of Florida, First District.

October 5, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Exhibit 99.1

 

 

ANNUAL COMPLIANCE REPORT

 

The undersigned, being an officer of U.S. Bank Trust National Association, as trustee (the “Trustee”), with respect to CorTSTrust For The Dow Chemical Company Debentures, on whose behalf  Structured Products Corp. has prepared this annual report on Form 10-K for the fiscal year ended December 31, 2009 (the “Annual Report”), certifies as follows:

 

1.         The Trustee is the trustee under the trust agreement.

 

2.         Based on my knowledge, for the periods included in the year covered by the Annual Report, the Trustee has fulfilled its obligations, including any servicing obligations, under the trust agreement.

 

 

 

**            /s/ Janet P. O'Hara       **

Name:   Janet P. O'Hara

Title:     Assistant Vice President

Date:     March 29, 2010

 

 

 

 

----
EXHIBIT 32.1



CERTIFICATION PURSUANT
TO

18 U.S.C. SECTION 1350AS ADOPTED PURSUANT TO



SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the
Report of DynaResource, Inc. on Form 10-Q/A for the period ended March 31, 2019 as filed with the Securities and Exchange Commission
on the date hereof (the "Report"), the undersigned, in the capacities and on the dates indicated below, hereby certifies
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his
knowledge:

1. The Report fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information
contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

|/s/ K.W. (“K.D.”)
        Diepholz
        K.W. (“K.D.”) Diepholz
        Chairman of the Board of Directors
        Dated:  October 2, 2019
        /s/ K.W. (“K.D.”) Diepholz
        K.W. (“K.D.”) Diepholz
        Chief Executive Officer
        Dated:  October 2, 2019
        /s/ K.W. (“K.D.”) Diepholz
        K.W. (“K.D.”) Diepholz;
        Chief Financial Officer
        Dated:  October 2, 2019
        /s/ K.W. (“K.D.”) Diepholz
        K.W. (“K.D.”) Diepholz;
        Principal Accounting Officer
        Dated:  October 2, 2019
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

This
certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the
extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended.